Thyroid crisis caused by metastatic thyroid cancer: an autopsy case report.


Journal

BMC endocrine disorders
ISSN: 1472-6823
Titre abrégé: BMC Endocr Disord
Pays: England
ID NLM: 101088676

Informations de publication

Date de publication:
24 Oct 2021
Historique:
received: 30 03 2021
accepted: 15 10 2021
entrez: 25 10 2021
pubmed: 26 10 2021
medline: 12 2 2022
Statut: epublish

Résumé

Thyroid crisis is a life-threatening condition in thyrotoxic patients. Although differentiated thyroid cancer is one of the causes of hyperthyroidism, reports on thyroid crisis caused by thyroid cancer are quite limited. Here, we describe a case of thyroid crisis caused by metastatic thyroid cancer. A 91-year-old woman was admitted to our hospital because of loss of appetite. Two years prior to this hospitalization, she presented with subclinical thyrotoxicosis and was diagnosed with histologically unidentified thyroid cancer with multiple metastases, and she refused aggressive medical interventions. On admission, she exhibited extreme thyrotoxicosis, and the presence of fever, severe tachycardia, impaired consciousness, and heart failure revealed the presence of thyroid crisis. All thyroid autoantibodies were negative. Multidisciplinary conservative treatment was initiated; however, she died on the fifth day after admission. Autopsy revealed the presence of primary anaplastic thyroid carcinoma and multiple metastatic foci arising from follicular thyroid carcinoma. Both primary and metastatic follicular thyroid carcinoma likely induced thyrotoxicosis, which could have been exacerbated by anaplastic thyroid carcinoma. Even though the trigger of thyroid crisis in this patient is not clear, the aggravated progression of her clinical course suggests that careful monitoring of thyroid hormones and appropriate intervention are essential for patients with thyroid cancer.

Sections du résumé

BACKGROUND BACKGROUND
Thyroid crisis is a life-threatening condition in thyrotoxic patients. Although differentiated thyroid cancer is one of the causes of hyperthyroidism, reports on thyroid crisis caused by thyroid cancer are quite limited. Here, we describe a case of thyroid crisis caused by metastatic thyroid cancer.
CASE PRESENTATION METHODS
A 91-year-old woman was admitted to our hospital because of loss of appetite. Two years prior to this hospitalization, she presented with subclinical thyrotoxicosis and was diagnosed with histologically unidentified thyroid cancer with multiple metastases, and she refused aggressive medical interventions. On admission, she exhibited extreme thyrotoxicosis, and the presence of fever, severe tachycardia, impaired consciousness, and heart failure revealed the presence of thyroid crisis. All thyroid autoantibodies were negative. Multidisciplinary conservative treatment was initiated; however, she died on the fifth day after admission. Autopsy revealed the presence of primary anaplastic thyroid carcinoma and multiple metastatic foci arising from follicular thyroid carcinoma. Both primary and metastatic follicular thyroid carcinoma likely induced thyrotoxicosis, which could have been exacerbated by anaplastic thyroid carcinoma.
CONCLUSIONS CONCLUSIONS
Even though the trigger of thyroid crisis in this patient is not clear, the aggravated progression of her clinical course suggests that careful monitoring of thyroid hormones and appropriate intervention are essential for patients with thyroid cancer.

Identifiants

pubmed: 34689780
doi: 10.1186/s12902-021-00875-7
pii: 10.1186/s12902-021-00875-7
pmc: PMC8543858
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

213

Informations de copyright

© 2021. The Author(s).

Références

Anesthesiology. 1997 Aug;87(2):433-5
pubmed: 9286911
J Endocrinol. 2011 Jan;208(1):89-96
pubmed: 20974636
Clin Endocrinol (Oxf). 2002 Apr;56(4):553-5
pubmed: 11966749
Int J Clin Pract. 2021 May;75(5):e14003
pubmed: 33403716
JAMA. 2017 Apr 4;317(13):1338-1348
pubmed: 28362912
Thyroid. 2001 May;11(5):501-10
pubmed: 11396709
Sci Rep. 2019 May 29;9(1):8028
pubmed: 31142771
Thyroid. 2018 Jan;28(1):32-40
pubmed: 28899229
Am J Obstet Gynecol. 1998 Sep;179(3 Pt 1):818-9
pubmed: 9757998
Endokrynol Pol. 2018;69(1):28-31
pubmed: 29319130
AACE Clin Case Rep. 2019 Jan 30;5(1):e7-e12
pubmed: 31966991
J Laryngol Otol. 2007 Jul;121(7):695-7
pubmed: 17156585
Mol Clin Oncol. 2019 Dec;11(6):535-550
pubmed: 31798874
Nat Rev Endocrinol. 2014 Mar;10(3):136-42
pubmed: 24342882
Thyroid. 2004 Nov;14(11):975-80
pubmed: 15671779
Endocr J. 2005 Oct;52(5):537-42
pubmed: 16284430
Eur Thyroid J. 2017 Sep;6(5):276-280
pubmed: 29071241
BMJ Case Rep. 2014 Oct 09;2014:
pubmed: 25301427
Thyroid. 2012 Jul;22(7):661-79
pubmed: 22690898
Lancet. 2016 Dec 3;388(10061):2783-2795
pubmed: 27240885
Lancet. 2016 Aug 27;388(10047):906-918
pubmed: 27038492

Auteurs

Kai Takedani (K)

Department of Internal Medicine 1, Faculty of Medicine, Shimane University, 89-1 Enya-cho, Izumo, Shimane, 693-8501, Japan.

Masakazu Notsu (M)

Department of Internal Medicine 1, Faculty of Medicine, Shimane University, 89-1 Enya-cho, Izumo, Shimane, 693-8501, Japan. mnotsu25@med.shimane-u.ac.jp.

Naoko Adachi (N)

Department of Internal Medicine 1, Faculty of Medicine, Shimane University, 89-1 Enya-cho, Izumo, Shimane, 693-8501, Japan.

Sayuri Tanaka (S)

Department of Internal Medicine 1, Faculty of Medicine, Shimane University, 89-1 Enya-cho, Izumo, Shimane, 693-8501, Japan.

Masahiro Yamamoto (M)

Department of Internal Medicine 1, Faculty of Medicine, Shimane University, 89-1 Enya-cho, Izumo, Shimane, 693-8501, Japan.

Mika Yamauchi (M)

Department of Internal Medicine 1, Faculty of Medicine, Shimane University, 89-1 Enya-cho, Izumo, Shimane, 693-8501, Japan.

Naotake Yamauchi (N)

Department of Pathology, Faculty of Medicine, Shimane University, 89-1 Enya-cho, Izumo, Shimane, 693-8501, Japan.
Department of Pathology, Faculty of Medicine, University of Toyama, 2630 Sugitani, Toyama, Toyama, 930-0194, Japan.

Riruke Maruyama (R)

Department of Pathology, Faculty of Medicine, Shimane University, 89-1 Enya-cho, Izumo, Shimane, 693-8501, Japan.

Keizo Kanasaki (K)

Department of Internal Medicine 1, Faculty of Medicine, Shimane University, 89-1 Enya-cho, Izumo, Shimane, 693-8501, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH